Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVBP ArriVent BioPharma	$31.73 +0.6%	$31.18	$16.10 ▼ $35.83	$1.48B	1.29	564,580 shs	474,966 shs
FENC Adherex Technologies	$9.99 -1.6%	$9.93	$5.65 ▼ $11.31	$349.99M	1.07	213,865 shs	90,005 shs
MLTX MoonLake Immunotherapeutics	$19.02 -1.8%	$18.97	$5.95 ▼ $62.75	$1.40B	1.04	1.16 million shs	650,755 shs
PAHC Phibro Animal Health	$34.03 0.0%	$32.45	$25.58 ▼ $60.08	$1.38B	0.46	287,203 shs	137,276 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVBP ArriVent BioPharma	+0.60%	-4.40%	-1.12%	+4.31%	+44.95%
FENC Adherex Technologies	-1.58%	-4.86%	-3.94%	+46.05%	+14.43%
MLTX MoonLake Immunotherapeutics	-1.76%	-3.35%	-4.90%	+10.71%	-65.88%
PAHC Phibro Animal Health	-0.03%	+2.16%	+8.51%	-38.31%	+14.23%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AVBP ArriVent BioPharma	$31.73 +0.6%	$31.18	$16.10 ▼ $35.83	$1.48B	1.29	564,580 shs	474,966 shs
FENC Adherex Technologies	$9.99 -1.6%	$9.93	$5.65 ▼ $11.31	$349.99M	1.07	213,865 shs	90,005 shs
MLTX MoonLake Immunotherapeutics	$19.02 -1.8%	$18.97	$5.95 ▼ $62.75	$1.40B	1.04	1.16 million shs	650,755 shs
PAHC Phibro Animal Health	$34.03 0.0%	$32.45	$25.58 ▼ $60.08	$1.38B	0.46	287,203 shs	137,276 shs

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AVBP ArriVent BioPharma	+0.60%	-4.40%	-1.12%	+4.31%	+44.95%
FENC Adherex Technologies	-1.58%	-4.86%	-3.94%	+46.05%	+14.43%
MLTX MoonLake Immunotherapeutics	-1.76%	-3.35%	-4.90%	+10.71%	-65.88%
PAHC Phibro Animal Health	-0.03%	+2.16%	+8.51%	-38.31%	+14.23%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AVBP ArriVent BioPharma	2.78	Moderate Buy	$44.83	41.30% Upside
FENC Adherex Technologies	2.71	Moderate Buy	$15.40	54.15% Upside
MLTX MoonLake Immunotherapeutics	2.41	Hold	$24.21	27.31% Upside
PAHC Phibro Animal Health	2.00	Hold	$42.50	24.89% Upside

Current Analyst Ratings Breakdown

Latest FENC, AVBP, MLTX, and PAHC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/20/2026	MLTX MoonLake Immunotherapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$45.00
7/17/2026	AVBP ArriVent BioPharma	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/17/2026	FENC Adherex Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D-)
7/1/2026	MLTX MoonLake Immunotherapeutics	Leerink Partners Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$24.00 ➝ $29.00
6/15/2026	PAHC Phibro Animal Health	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy (B-) ➝ Hold (C+)
6/9/2026	MLTX MoonLake Immunotherapeutics	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$30.00
6/8/2026	MLTX MoonLake Immunotherapeutics	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$45.00
5/29/2026	AVBP ArriVent BioPharma	Truist Financial Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$43.00 ➝ $45.00
5/25/2026	FENC Adherex Technologies	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
5/22/2026	AVBP ArriVent BioPharma	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Overweight
5/22/2026	FENC Adherex Technologies	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$13.00 ➝ $16.00

(Data available from 7/25/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AVBP ArriVent BioPharma	N/A	N/A	N/A	N/A	$7.44 per share	N/A
FENC Adherex Technologies	$44.64M	7.84	N/A	N/A	$1.04 per share	9.61
MLTX MoonLake Immunotherapeutics	N/A	N/A	N/A	N/A	$4.27 per share	N/A
PAHC Phibro Animal Health	$1.30B	1.06	$3.27 per share	10.41	$7.05 per share	4.83

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AVBP ArriVent BioPharma	-$166.31M	-$3.47	N/A	N/A	N/A	N/A	-48.98%	-45.44%	8/14/2026 (Estimated)
FENC Adherex Technologies	-$9.74M	-$0.29	N/A	10.86	N/A	-17.12%	-43.87%	-11.35%	8/13/2026 (Estimated)
MLTX MoonLake Immunotherapeutics	-$227.32M	-$3.87	N/A	N/A	N/A	N/A	-85.15%	-60.52%	8/4/2026 (Estimated)
PAHC Phibro Animal Health	$48.26M	$2.33	14.61	10.22	0.48	6.35%	37.14%	8.57%	8/26/2026 (Estimated)

Latest FENC, AVBP, MLTX, and PAHC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	AVBP ArriVent BioPharma	-$0.98	N/A	N/A	N/A	N/A	N/A
8/13/2026	Q2 2026	FENC Adherex Technologies	$0.01	N/A	N/A	N/A	$16.21 million	N/A
8/4/2026	Q2 2026	MLTX MoonLake Immunotherapeutics	-$0.90	N/A	N/A	N/A	N/A	N/A
5/14/2026	Q1 2026	FENC Adherex Technologies	-$0.02	$0.01	+$0.03	$0.01	$13.90 million	$15.11 million
5/11/2026	Q1 2026	AVBP ArriVent BioPharma	-$0.88	-$0.96	-$0.08	-$0.96	N/A	N/A
5/11/2026	Q1 2026	MLTX MoonLake Immunotherapeutics	-$0.91	-$0.98	-$0.07	-$0.98	N/A	N/A
5/6/2026	Q3 2026	PAHC Phibro Animal Health	$0.72	$0.76	+$0.04	$0.59	$367.02 million	$383.54 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
AVBP ArriVent BioPharma	N/A	N/A	N/A	N/A	N/A
FENC Adherex Technologies	N/A	N/A	N/A	N/A	N/A
MLTX MoonLake Immunotherapeutics	N/A	N/A	N/A	N/A	N/A
PAHC Phibro Animal Health	$0.48	1.41%	N/A	20.60%	N/A

Latest FENC, AVBP, MLTX, and PAHC Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
5/5/2026	PAHC Phibro Animal Health	quarterly	$0.12	1.51%	6/3/2026	6/3/2026	6/24/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AVBP ArriVent BioPharma	N/A	13.95	13.95
FENC Adherex Technologies	N/A	6.98	6.78
MLTX MoonLake Immunotherapeutics	0.39	8.60	8.60
PAHC Phibro Animal Health	1.97	3.17	1.26

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AVBP ArriVent BioPharma	9.48%
FENC Adherex Technologies	55.51%
MLTX MoonLake Immunotherapeutics	93.85%
PAHC Phibro Animal Health	99.34%

Insider Ownership

Company	Insider Ownership
AVBP ArriVent BioPharma	8.58%
FENC Adherex Technologies	10.73%
MLTX MoonLake Immunotherapeutics	10.40%
PAHC Phibro Animal Health	50.13%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AVBP ArriVent BioPharma	40	46.58 million	42.58 million	N/A
FENC Adherex Technologies	10	35.03 million	31.28 million	Optionable
MLTX MoonLake Immunotherapeutics	2	73.62 million	65.96 million	Optionable
PAHC Phibro Animal Health	2,475	40.56 million	20.23 million	Optionable

FENC, AVBP, MLTX, and PAHC Headlines

Recent News About These Companies

Walleye Capital LLC Has $1.53 Million Stake in Phibro Animal Health Corporation $PAHC

July 24 at 5:46 AM | marketbeat.com

Allspring Global Investments Holdings LLC Acquires 169,628 Shares of Phibro Animal Health Corporation $PAHC

July 22 at 3:04 AM | marketbeat.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Consensus Recommendation of "Hold" from Analysts

July 21, 2026 | marketbeat.com

Livforsakringsbolaget Skandia Omsesidigt Acquires Shares of 31,800 Phibro Animal Health Corporation $PAHC

July 15, 2026 | marketbeat.com

52,998 Shares in Phibro Animal Health Corporation $PAHC Acquired by Advisors Preferred LLC

July 15, 2026 | marketbeat.com

Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term

July 14, 2026 | zacks.com

Phibro Animal Health (PAHC) Leaves Russell Indexes, Is The Stock A Bargain?

July 9, 2026 | finance.yahoo.com

PAHC or LZAGY: Which Is the Better Value Stock Right Now?

July 9, 2026 | zacks.com

Phibro Animal Health (PAHC) Stock Looks Reasonable On Value But Stretched After 138% Gain

July 9, 2026 | finance.yahoo.com

Phibro Animal Health (PAHC) Stock Loses Russell Index Spots And Investor Visibility

July 9, 2026 | finance.yahoo.com

Cvfg LLC Acquires New Position in Phibro Animal Health Corporation $PAHC

July 8, 2026 | marketbeat.com

Implied volatility surging for Phibro Animal Health stock options

July 8, 2026 | msn.com

Q1 rundown: Phibro Animal Health (NASDAQ:PAHC) vs other branded pharmaceuticals stocks

July 1, 2026 | msn.com

Capricorn Fund Managers Ltd Has $14.77 Million Holdings in Phibro Animal Health Corporation $PAHC

July 1, 2026 | marketbeat.com

2 healthcare stocks for long-term investors and 1 we turn down

June 30, 2026 | msn.com

Wall Street analysts predict a 36.23% upside in Phibro (PAHC): Here's what you should know

June 29, 2026 | msn.com

Phibro Animal Health Corporation (NASDAQ:PAHC) Receives Consensus Rating of "Hold" from Analysts

June 26, 2026 | marketbeat.com

PAHC vs. SYK: Which Stock Is the Better Value Option?

June 22, 2026 | zacks.com

Phibro Animal Health Corporation: Stable But Limited Near-Term Upside

June 19, 2026 | seekingalpha.com

What makes Phibro (PAHC) a new buy stock

June 17, 2026 | msn.com

Should You Continue to Hold PAHC Stock in Your Portfolio?

June 15, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC, AVBP, MLTX, and PAHC Company Descriptions

ArriVent BioPharma NASDAQ:AVBP

$31.73 +0.19 (+0.60%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$31.72 0.00 (-0.02%)

As of 07/24/2026 05:21 PM Eastern

ArriVent BioPharma, Inc. operates as a clinical-stage biopharmaceutical company that engages in the identification, development, and commercialization of medicines for the unmet medical needs of patients with cancers in the United States. It also engages in the development and commercialization of targeted cancer therapies for non-small cell lung cancer (NSCLC) and other solid tumors. In addition, the company develops Furmonertinib, a third-generation tyrosine kinase inhibitor that is in multiple clinical trials across a range of epidermal growth factor receptor mutations (EFGRm) in non-small cell lung cancer (NSCLC), including a phase 3 clinical trial for treatment of patients with metastatic EFGRm NSCLC; phase 1b clinical trial for treatment of patients with NSCLC with other EGFR mutations and NSCLC with HER2 Exon 20 insertion mutations; and ARR-002. It has strategic collaborations with Aarvik Therapeutics Inc. to discover and develop antibody drug conjugates (ADCs) with improved activity and safety over single target bivalent ADCs; and Shanghai Allist Pharmaceuticals Co., Ltd. to develop and commercialize Furmonertinib. The company was incorporated in 2021 and is based in Newtown Square, Pennsylvania.

Adherex Technologies NASDAQ:FENC

$9.99 -0.16 (-1.58%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$9.98 -0.02 (-0.15%)

As of 07/24/2026 07:34 PM Eastern

Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. Its lead product candidate is the Sodium Thiosulfate, which has completed the Phase III clinical trial for the prevention of cisplatin induced hearing loss or ototoxicity in children. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was founded in 1996 and is based in Research Triangle Park, North Carolina.

MoonLake Immunotherapeutics NASDAQ:MLTX

$19.02 -0.34 (-1.76%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$19.16 +0.14 (+0.74%)

As of 07/24/2026 07:34 PM Eastern

MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It develops Sonelokimab, a novel investigational Nanobody for the treatment of inflammation diseases; and hidradenitis suppurativa, psoriatic arthritis, axial spondyloarthritis, and psoriasis. MoonLake Immunotherapeutics was incorporated in 2020 and is headquartered in Zug, Switzerland.

Phibro Animal Health NASDAQ:PAHC

$34.03 -0.01 (-0.03%)

Closing price 07/24/2026 04:00 PM Eastern

Extended Trading

$34.09 +0.06 (+0.18%)

As of 07/24/2026 07:34 PM Eastern

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in development, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, manganese, copper, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was founded in 1946 and is headquartered in Teaneck, New Jersey.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FENC, AVBP, MLTX, and PAHC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FENC, AVBP, MLTX, and PAHC Earnings

Compare Dividends

Latest FENC, AVBP, MLTX, and PAHC Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FENC, AVBP, MLTX, and PAHC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC, AVBP, MLTX, and PAHC Company Descriptions

ArriVent BioPharma NASDAQ:AVBP

Adherex Technologies NASDAQ:FENC

MoonLake Immunotherapeutics NASDAQ:MLTX

Phibro Animal Health NASDAQ:PAHC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest FENC, AVBP, MLTX, and PAHC Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest FENC, AVBP, MLTX, and PAHC Earnings

Compare Dividends

Latest FENC, AVBP, MLTX, and PAHC Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

FENC, AVBP, MLTX, and PAHC Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

FENC, AVBP, MLTX, and PAHC Company Descriptions

ArriVent BioPharma NASDAQ:AVBP

Adherex Technologies NASDAQ:FENC

MoonLake Immunotherapeutics NASDAQ:MLTX

Phibro Animal Health NASDAQ:PAHC

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools